2016
DOI: 10.4103/0976-3147.181481
|View full text |Cite
|
Sign up to set email alerts
|

A clinical study of neurological soft signs in patients with schizophrenia

Abstract: Background and Aim:Neurological soft signs (NSSs) are “objectively measured, nonlocalizing abnormalities, not related to impairment of a specific brain region, reflecting improper cortical-subcortical and intercortical connections.” The possibility of NSS as an endophenotype in schizophrenia has been studied across the globe. We aimed at finding the prevalence of NSS among patients with schizophrenia as well as the associations of NSS between various sociodemographic and illness variables.Subjects and Methods:… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
3
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(8 citation statements)
references
References 27 publications
0
3
0
1
Order By: Relevance
“…In our study, 244 patients were enrolled, meeting the test power of 0.8. Eligible patients for this study had to meet the following enrollment criteria: (1) an ICD-10 diagnosis of schizophrenia [32], (2) age within the range of 18-60 years, (3) illness duration of no less than 2 years, (4) a current live-in caregiver who provides most of the care, (5) maintenance treatment with one of the following 7 antipsychotics: chlorpromazine, sulpiride, clozapine, risperidone, haloperidol, olanzapine, and aripiprazole, (6) total scores on the Positive and Negative Syndrome Scale (PANSS) of no more than 60, and (7) no formal training or regular practice of Tai-chi prior to enrollment. The 7 antipsychotics were selected because more than 90% of patients with schizophrenia in China were prescribed at least 1 of these medications [33].…”
Section: Methodsmentioning
confidence: 99%
“…In our study, 244 patients were enrolled, meeting the test power of 0.8. Eligible patients for this study had to meet the following enrollment criteria: (1) an ICD-10 diagnosis of schizophrenia [32], (2) age within the range of 18-60 years, (3) illness duration of no less than 2 years, (4) a current live-in caregiver who provides most of the care, (5) maintenance treatment with one of the following 7 antipsychotics: chlorpromazine, sulpiride, clozapine, risperidone, haloperidol, olanzapine, and aripiprazole, (6) total scores on the Positive and Negative Syndrome Scale (PANSS) of no more than 60, and (7) no formal training or regular practice of Tai-chi prior to enrollment. The 7 antipsychotics were selected because more than 90% of patients with schizophrenia in China were prescribed at least 1 of these medications [33].…”
Section: Methodsmentioning
confidence: 99%
“…The mean age of the participants (in years) was 33.42, with a range of 18 to 60 years, which was similar to that described in the literature. According to a study done on Schizophrenia patients, most of the participants were in the age range of 20 to 39 years (69%) with a mean age (in years) of 32.02 [ 12 ].…”
Section: Discussionmentioning
confidence: 99%
“…7,8 In addition, they provide the ability to perform scalable bedside assessment without costly and sophisticated equipment. 9 While NSS in illnesses were first identified in the mid-to late-1960s, 10,11 they have yet to transform the psychiatric landscape. Similar to other biomarker research, questions around reliability and validity of NSS scales have emerged as research has expanded.…”
Section: Introductionmentioning
confidence: 99%
“…NSS offer important benefits, including a direct connection between clinical presentation and neurological functioning 7,8 . In addition, they provide the ability to perform scalable bedside assessment without costly and sophisticated equipment 9 …”
Section: Introductionmentioning
confidence: 99%